MXPA00002250A - Improvements in or relating to the preparation of lactam compounds - Google Patents
Improvements in or relating to the preparation of lactam compoundsInfo
- Publication number
- MXPA00002250A MXPA00002250A MXPA/A/2000/002250A MXPA00002250A MXPA00002250A MX PA00002250 A MXPA00002250 A MX PA00002250A MX PA00002250 A MXPA00002250 A MX PA00002250A MX PA00002250 A MXPA00002250 A MX PA00002250A
- Authority
- MX
- Mexico
- Prior art keywords
- solvent
- compound
- acid
- enzyme
- apa
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims description 8
- -1 lactam compounds Chemical class 0.000 title description 4
- 150000001875 compounds Chemical class 0.000 claims abstract description 75
- 239000002904 solvent Substances 0.000 claims abstract description 61
- NGHVIOIJCVXTGV-ALEPSDHESA-N 6-APA Chemical compound [O-]C(=O)[C@H]1C(C)(C)S[C@@H]2[C@H]([NH3+])C(=O)N21 NGHVIOIJCVXTGV-ALEPSDHESA-N 0.000 claims abstract description 59
- 238000006243 chemical reaction Methods 0.000 claims abstract description 50
- SJSYJHLLBBSLIH-SDNWHVSQSA-N (E)-3-(2-methoxyphenyl)-2-phenylprop-2-enoic acid Chemical compound COC1=CC=CC=C1\C=C(\C(O)=O)C1=CC=CC=C1 SJSYJHLLBBSLIH-SDNWHVSQSA-N 0.000 claims abstract description 38
- WLJVXDMOQOGPHL-UHFFFAOYSA-N Phenylacetic acid Natural products OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 claims abstract description 38
- 229960003424 phenylacetic acid Drugs 0.000 claims abstract description 38
- 239000003279 phenylacetic acid Substances 0.000 claims abstract description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 27
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims abstract description 17
- LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-Tetrafluoroethane Chemical compound FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000011877 solvent mixture Substances 0.000 claims abstract description 10
- 229940056360 Penicillin G Drugs 0.000 claims abstract description 8
- 230000002255 enzymatic Effects 0.000 claims abstract description 8
- 238000001914 filtration Methods 0.000 claims abstract description 7
- 239000006227 byproduct Substances 0.000 claims abstract description 5
- 150000003951 lactams Chemical class 0.000 claims abstract description 5
- 239000011356 non-aqueous organic solvent Substances 0.000 claims abstract 2
- 238000000638 solvent extraction Methods 0.000 claims abstract 2
- 108090000790 Enzymes Proteins 0.000 claims description 43
- 102000004190 Enzymes Human genes 0.000 claims description 43
- 238000002955 isolation Methods 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 17
- 239000002253 acid Substances 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 13
- 238000007792 addition Methods 0.000 claims description 10
- 230000000694 effects Effects 0.000 claims description 10
- 229960000626 benzylpenicillin Drugs 0.000 claims description 9
- 238000001556 precipitation Methods 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 9
- 239000011780 sodium chloride Substances 0.000 claims description 9
- 229940049954 Penicillin Drugs 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 238000009835 boiling Methods 0.000 claims description 7
- 125000004432 carbon atoms Chemical group C* 0.000 claims description 7
- 239000003125 aqueous solvent Substances 0.000 claims description 6
- 238000000855 fermentation Methods 0.000 claims description 6
- 230000004151 fermentation Effects 0.000 claims description 6
- 150000001780 cephalosporins Chemical class 0.000 claims description 5
- 238000005947 deacylation reaction Methods 0.000 claims description 5
- 239000002244 precipitate Substances 0.000 claims description 5
- 238000000926 separation method Methods 0.000 claims description 5
- NVIAYEIXYQCDAN-CLZZGJSISA-N 7β-aminodeacetoxycephalosporanic acid Chemical compound S1CC(C)=C(C(O)=O)N2C(=O)[C@@H](N)[C@@H]12 NVIAYEIXYQCDAN-CLZZGJSISA-N 0.000 claims description 4
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 4
- 239000008346 aqueous phase Substances 0.000 claims description 4
- 239000003054 catalyst Substances 0.000 claims description 4
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims description 3
- 230000003197 catalytic Effects 0.000 claims description 3
- 239000012071 phase Substances 0.000 claims description 3
- 230000001851 biosynthetic Effects 0.000 claims description 2
- OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 claims description 2
- 125000005750 substituted cyclic groups Chemical group 0.000 claims description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 42
- ANIAQSUBRGXWLS-UHFFFAOYSA-N Trichloronate Chemical compound CCOP(=S)(CC)OC1=CC(Cl)=C(Cl)C=C1Cl ANIAQSUBRGXWLS-UHFFFAOYSA-N 0.000 description 27
- 239000000243 solution Substances 0.000 description 19
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 12
- 239000006184 cosolvent Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- 239000007864 aqueous solution Substances 0.000 description 7
- GRYLNZFGIOXLOG-UHFFFAOYSA-N nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 7
- 239000011347 resin Substances 0.000 description 7
- 229920005989 resin Polymers 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 108010073038 EC 3.5.1.11 Proteins 0.000 description 4
- 108010093096 Immobilized Enzymes Proteins 0.000 description 4
- BPLBGHOLXOTWMN-MBNYWOFBSA-N Phenoxymethylpenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)COC1=CC=CC=C1 BPLBGHOLXOTWMN-MBNYWOFBSA-N 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 238000006911 enzymatic reaction Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 229910052731 fluorine Inorganic materials 0.000 description 4
- YCKRFDGAMUMZLT-UHFFFAOYSA-N fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 230000002829 reduced Effects 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 108020003076 Amidases Proteins 0.000 description 2
- 102000005922 Amidases Human genes 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 238000004166 bioassay Methods 0.000 description 2
- 230000003115 biocidal Effects 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 150000001983 dialkylethers Chemical class 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229960004331 phenoxymethylpenicillin Drugs 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000000284 resting Effects 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- QQZOPKMRPOGIEB-UHFFFAOYSA-N 2-Hexanone Chemical compound CCCCC(C)=O QQZOPKMRPOGIEB-UHFFFAOYSA-N 0.000 description 1
- 108090000531 Amidohydrolases Proteins 0.000 description 1
- 102000004092 Amidohydrolases Human genes 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- RXKJFZQQPQGTFL-UHFFFAOYSA-N Dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 229940056367 Penicillin V Drugs 0.000 description 1
- AZCVBVRUYHKWHU-MBNYWOFBSA-N Penicillin X Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=C(O)C=C1 AZCVBVRUYHKWHU-MBNYWOFBSA-N 0.000 description 1
- 102000035443 Peptidases Human genes 0.000 description 1
- 108091005771 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L Sulphite Chemical compound [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 150000001345 alkine derivatives Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000005078 alkoxycarbonylalkyl group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 1
- 125000003460 beta-lactamyl group Chemical group 0.000 description 1
- 230000003851 biochemical process Effects 0.000 description 1
- 235000010633 broth Nutrition 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 125000004997 halocarbonyl group Chemical group 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atoms Chemical class [H]* 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 239000005445 natural product Substances 0.000 description 1
- 229930014626 natural products Natural products 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 235000019371 penicillin G benzathine Nutrition 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001888 polyacrylic acid Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002952 polymeric resin Substances 0.000 description 1
- 229920005553 polystyrene-acrylate Polymers 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N potassium ion Chemical group [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000000717 retained Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N sodium cation Chemical group [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 229910001415 sodium ion Chemical group 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002132 β-lactam antibiotic Substances 0.000 description 1
Abstract
Lactams, for example 6-aminopenicillanic acid (6-APA), may be prepared by enzymatic conversion of a first compound, for example penicillin-G, in a solvent mixture comprising water and a non-aqueous organic solvent, especially 1,1,1,2-tetrafluoroethane. The 6-APA can be caused to precipitate, isolated by filtration and optionally derivatised to produce a desired compound. A by-product of the enzymatic conversion, phenylacetic acid, can be isolated by solvent extraction, suitably using a solvent which also comprises 1,1,1,2-tetrafluoroethane.
Description
IMPROVED PROCEDURE FOR THE PREPARATION OF LACTAMA COMPOUNDS
X.ESCJB.IPTION OF THE INVENTION
This invention relates to the preparation of a compound, especially an active pharmaceutical compound. Particularly, although not exclusively, the invention relates to the preparation of lactams, for example penicillins and cephalosporins and / or derivatives thereof. 6-aminopenicillanic acid (6-APA) _ and 7-aminodesacetoxycephalosporanic acid (7-ADCA) are intermediates used for the manufacture of most of the semisynthetic ß-lactam antibiotics. The commercially preferred method for the manufacture of 6-APA is by means of biochemical deacylation of benzyl-penicillin, commonly known as Pen-G or the equivalent enzymatic deacylation of phenoxymethyl-penicillin, commonly known as Pen-V. This is accomplished by using an enzyme such as penicillin acylase, which has been immobilized on an insoluble matrix such as polystyrene or polyacrylate polymers or copolymers. REF .: 32825
Various processes that use this technique are illustrated in the scientific literature. In such processes, penicillin G is isolated from a fermentation liquor as a solid intermediate using known means, and is then dissolved in water in a relatively dilute solution (for example 5% w / v). The enzyme reaction (shown in reaction scheme 1 below where R represents a potassium or sodium ion) is carried out at an elevated temperature (for example 35 to 40 ° C). The phenylacetic acid (PAA) produced is neutralized by the continuous addition of dilute aqueous sodium hydroxide (for example to 5% w / v) to maintain a pH of around 8.0. The isolation of 6-APA is usually carried out by the concentration of the liquors of the enzyme reaction, for example up to 15% with respect to 6-APA, in order to maximize the yield, followed by the precipitation with an acid diluted inorganic, such as 5% nitric acid or sulfuric acid. The PAA is removed by extraction in a non-miscible organic solvent, such as methyl isobutyl ketone or butyl acetate. The 6-APA is finally removed by filtration, washed with acetone then vacuum dried. A standard conversion performance
acceptable for the deacylation process described is 94 to 96% - and is 82 to 86% for the precipitation and isolation stage.
REACTION SCHEME 1
C s COONa
PENICILLIN G 6 -APA PAA
The immobilized enzymes used in the above-described process may be sensitive to the inhibition of the product. Hence, the reaction is carried out normally in relatively dilute solutions. A drawback of this is that the solubility of 6-APA in water is about 2%, which means that a concentration step is necessary in order to minimize the product losses in the mother liquors. An expensive concentration step is therefore often applied to increase the 6-APA content to 12-16%.
PAA is one of the ingredients normally used in the fermentation of penicillin G. Therefore, it is commercially advantageous to recover PAA from the reaction effluent so that it can be recycled. Conventional methods used commercially for the recovery of PAA employ a multi-step process involving a combination of two or more of the following techniques: vacuum distillation, purification (for example carbon treatment), extraction in an aqueous phase, chromatography , precipitation, filtration and drying. These techniques are relatively expensive and environmentally problematic. An objective of this invention is to face the problems described above. According to a first aspect of the invention, there is provided a method for preparing a second compound by the catalytic conversion of a first compound, the method comprising contacting the first compound and a catalyst in a solvent mixture comprising water and a first non-aqueous solvent. Unless stated otherwise, or the context requires otherwise, a reference
any compound herein includes a reference to a salt of the compound. Said catalyst is preferably an enzyme. The enzyme can be sensitive to the second compound, for example in the sense that relatively high concentrations of the second compound can reduce the ability of the enzyme to effect the conversion - an effect known as "product inhibition." Said enzyme is preferably capable of catalyzing a deacylation reaction This can suitably comprise an acylase which can be produced from any penicillin-acylase producing microorganism such as Escherichia, especially Esch eri chi a co li, Ps eudomonas,
Streptomyces, Pro t eus and My crococus. Said enzyme is preferably immobilized, suitably by physical absorption or binding to an insoluble, solid matrix. The first compound is preferably of the general formula R1NHQ wherein R1 represents an optionally substituted alkylcarbonyl group and Q represents an optionally substituted cyclic group, especially an optionally substituted lactam, for example a β-lactam group.
Unless stated otherwise, an optionally substituted alkyl group may have up to 12, preferably up to 8, more preferably up to 6, especially up to 4, carbon atoms. Optional substituents of an alkyl group include the aryl, alkenyl, alkynyl, acyl, nitro, cyano, alkoxy, hydroxyl, amino, alkylamino, sulfinyl, alkylsulfinyl, sulfonyl, alkylsulfonyl, sulfonate, amido, alkylamido, alkoxycarbonyl, halocarbonyl and haloalkyl groups optionally substituted, and halogen, especially fluorine, chlorine or bromine. Preferred optional substituents of the alkylcarbonyl group include optionally substituted, especially unsubstituted phenyl, carboxyl and amino groups. In the preferred embodiments, the group R1 may be an optionally substituted benzylcarbonyl group or a group C (COOH) (NH2) HCH2CH2CH2C (0) - or a salt thereof. Said group Q may comprise a lactam fused to another optionally substituted cyclic portion which may be a 5 or 6 membered ring.
The first compound can be a natural product, especially a product of a fermentation reaction or a derivative thereof. The first compound is preferably an antibiotic. The method of the first aspect can include the step of preparing the first compound by a biochemical process, especially a fermentation. The ratio of the weight of the first solvent to that of the water in the solvent mixture can be at least 2, preferably at least 5, more preferably at least 7, especially at least 10. In some cases, this can be at least 15 or more. 20. Said proportion may be less than 100, preferably less than 50, more preferably less than 30, especially 20 or less. The proportion referred to is suitably present at any time during the conversion reaction, but preferably refers to the ratio at the start of the reaction. The ratio, as% w / v, of the first compound to the water present in said mixture may be at least 10, suitably at least 20, preferably at least 30, more preferably at least 40, especially 50 or more. The proportion can be less than 100, adequately less than 90,
preferably 80 or less. The aforementioned ratio is suitably present at any time during the conversion reaction, but preferably it refers to the ratio at the start of the reaction. Said first non-aqueous solvent may have a boiling point, at atmospheric pressure, less than 80 ° C, suitably less than 60 ° C, preferably less than 40 ° C, more preferably less than 20 ° C. Especially preferred solvents have a boiling point lower than 0 ° C, preferably lower than -10 ° C. The boiling point can be higher than -90 ° C, preferably higher than -70 ° C, more preferably greater than -50 ° C. The first solvent is preferably organic. This may be aromatic, but is preferably aliphatic. This may include less than 10, suitably less than 8, preferably less than 6, more preferably less than 4, especially 2 or fewer carbon atoms. This may be an optionally substituted alkane, alkene or alkyne. Alkanes of 1 to 4 optionally substituted carbon atoms are preferred. It is preferably halogenated. This can include less than 10, suitably less than 8,
preferably less than 6, more preferably less than 5, especially 4 or less halogen atoms. Preferred halogen atoms include fluorine, chlorine and bromine, with the fluorine and chlorine atom being preferred and the fluorine atoms being especially preferred. Preferably, the first solvent is non-chlorinated. It preferably comprises one or more carbon atoms, fluorine and hydrogen, only. Preferably, the first solvent is tetrafluoroethane, with 1,1,1,2-tetrafluoroethane which is especially preferred. The solvent mixture may include other solvents. The second compound, particularly when it is in the form of a free acid (for example when it is not a salt), can be at least 0.1%, suitably at least 0.5%, preferably at least 1.0%, more preferably at least 1.5%, especially approximately 2% soluble in water. The above-mentioned solubilities are preferably measured at 5 ° C. The second compound in the salt form, for example as an alkali metal salt, may have a solubility in water of at least 5% w / v,
preferably at least 10% w / v, more preferably at least 15% w / v. The method preferably includes the step of adjusting the pH of the reaction mixture during the conversion reaction, suitably to maintain it within a physiologically acceptable pH range. The pH is preferably in the range of 7 to 9, more preferably in the range of 7.8 to 8.2. In a first embodiment, the method can include the isolation of the second compound from the other compounds / solvents. Isolation may include causing precipitation of the second compound and subsequent isolation of the precipitate by filtration. Precipitation can be caused by adjusting the pH at or near the PKa value of the second compound. The suitable pH may be less than 5, preferably less than 4. The suitable pH may be above 2.5, preferably above 3.5. Suitably, a substantially insoluble form of the second compound is produced. The pH can be conveniently adjusted by the addition of an aqueous solution of an acid such as 1 M or 2 M nitric acid or preferably 1 M or 2 M sulfuric acid.
second filtrate can be washed with a second solvent. The traces of the second solvent can be substantially or completely removed from the filtrate by evaporation. In a second embodiment of the invention, the method can include adjusting the pH in the presence of a second solvent to a value at which the second compound is substantially soluble in the aqueous phase of the solvent mixture, while the by-products of the reaction They are substantially soluble in the second non-miscible solvent phase of the solvent mixture. The suitable pH may be less than 2.5, more suitably less than 2. The pH may suitably be 1 or higher. The solution of the second solvent can be separated from the aqueous phase containing the second compound, by sedimentation and physical separation, whereby an aqueous reaction liquor containing the second compound is produced. The reaction liquor can be washed with an amount of the second solvent, in order to remove contaminating traces from the reaction by-products. The second compound can be precipitated from the reaction liquor by adjusting the pH with a suitable base to produce a form
substantially insoluble of the second compound. A suitable base may be an aqueous solution of sodium hydroxide, potassium hydroxide or ammonia. The pH can be adjusted appropriately above 2.5, more adequately above 3.5. The pH can suitably be less than 5, preferably less than 4. The yield of the second compound in the first or second embodiments can be maximized by stirring at reduced temperature, preferably between 2 and 10 ° C. The second compound can be isolated by filtration, washing and drying . The second solvent used in the first and second embodiments described preferably includes the first non-aqueous solvent, preferably in combination with a co-solvent. The co-solvent may include another first solvent of a type described herein. Preferably, however, this is of a different type. Said co-solvent is selected to affect the boiling point and / or the dissolution properties of the solvent for the first material. The boiling point of said co-solvent may be lower than 60 ° C, preferably lower than 30 ° C, more preferably lower than 15 ° C, especially lower than
° C. The boiling point of the co-solvent may be greater than -90 ° C, preferably greater than -70 ° C, more preferably greater than -50 ° C. Preferably, the second solvent includes a larger portion of the first solvent in combination with a minor portion of the co-solvent. Preferably, at least 90% by weight, more preferably at least 93% by weight, especially at least 97% by weight of the second solvent is comprised by the first, non-aqueous solvent, especially by a hydrofluorocarbon solvent. The remainder is preferably constituted of one or more co-solvents, as described. The co-solvent can be selected from hydrocarbons and ethers. Preferred hydrocarbons have up to six carbon atoms. These can be alicyclic or, preferably, aliphatic. These are preferably alkanes with methane, ethane, propane, and butane which are preferred. Preferred ethers are dialkyl ethers, for example dialkyl ethers of 1 to 4 carbon atoms, with dimethyl ether which is especially preferred. In the purification of the second compound using the second solvent, the second compound may be precipitated, suitably
by adjusting the pH as described above. In the method of the first aspect, the catalytic conversion can result in the preparation of the second compound and a third compound. The enzyme may be sensitive to the third compound, for example in the sense that relatively high concentrations of the third compound may reduce the ability of the enzyme to effect the conversion. Where the first compound is of the general formula R1NHQ./ said third compound may represent a compound of the formula R1COOH or a salt thereof. In this case, the second compound may represent a compound of the formula H2NQ or a salt thereof. The method of the first aspect may include the step of separating the second and third compounds from each other. This may involve the provision of a solvent (which may be the first or second solvents described) in which the second and third compounds (or salts thereof) have different solubilities and / or have different partition coefficients and use this property to effect the separation. The second and third compounds can be separated
using a mixture comprising the solvent and water. The third compound, especially a free acid thereof, is preferably substantially soluble in the solvent used for the separation. After isolation of the second compound it can be derivatized, suitably to produce an antibiotic. The first compound can be a natreral penicillin, or a biosynthetic penicillin prepared by the addition of a precursor to penicillin fermentation broths, or a cephalosporin. Preferably, the first compound is selected from Penicillin G, Penicillin X (p-hydroxyphenylpenicillin), Penicillin V
(phenoxymethylpenicillin) and cephalosporin G. The second compound is preferably 6-aminopenicillanic acid or 7-aminodesacetoxycephalosporanic acid; and the third compound can be optionally substituted, especially unsubstituted, phenylacetic acid. In one embodiment of the invention, the penicillin acylase enzyme which has been immobilized on an insoluble matrix is charged to a lined reaction vessel, followed by the required volume of
water and penicillin G is added while stirring. The reaction vessel is then sealed and applied under vacuum to reach the pressure of 10 mbars or less. The first solvent is charged to the reaction mixture. An aqueous solution of sodium hydroxide (range of 2.5 to 20% w / v or more) is introduced into the reaction to maintain a pH range of 7.0 to 9.0 especially of about pH 8.0. The reaction temperature is maintained at an approximately constant level throughout. A preferred temperature range is 20 to 50 ° C, more preferably from 30 to 40 ° C. At the end of the reaction, which is indicated by a constant pH reading without the need for the subsequent addition of aqueous NaOH solution, the reaction liquors are charged from the bottom of the reaction vessel into a second lined vessel (the evaporation vessel) via a line filter. The immobilized enzyme is thus recovered, washed with water and stored for later use. The clear filtered solution is cooled by the flow of a refrigerant through the liner. The preferred temperature is from 0 to 20 ° C, more preferably from 2 to 10 ° C. An aqueous solution of
an inorganic acid, such as 1-4 M nitric acid or 1-4 M sulfuric acid, is added slowly while stirring at a pH in the range of 3.5 to 4.0, with a pH of 3.8 which is ideal. During this operation, the phenylacetic acid (PAA) present as the sodium salt is converted to the free acid form which is soluble in the first solvent. While the PAA is extracted into the first solvent, the 6-APA (in the free acid form) is precipitated and is now present as a suspension. The reaction mixture can be stirred for an additional 30 minutes up to one hour, while keeping the pH and temperature constant. 6-APA can be convenient and simply isolated by charging the reaction mixture from the bottom of the evaporation vessel back into the reaction vessel via an in-line filter. Optionally, a filter element can be adjusted to the outlet of the bottom of the container, such as a wire mesh filter or a sintered glass. According to a second aspect of the invention, there is provided a method of removing a third compound (preferably an acid or acid salt, especially PAA), as described in
present, from a mass of material containing the compound, the method comprises: a) contacting the mass of the material with a solvent (for example the first solvent or especially the second solvent described herein) for charging the solvent with the third compound; and b) the separation of the charged solvent from the rest of the mass of the material. The third compound contacted in the method is preferably a free acid. In the method, the third compound can be isolated by allowing the solvent to evaporate. Any feature of any aspect of any invention or embodiment described therein may be combined with any feature of any aspect of any other invention or embodiment described herein. The specific embodiments of the invention will now be described by way of example. The following terms are used hereinafter: Pen-G: refers to penicillin G as shown in Reaction Scheme 1. 6-PAA: refers to 6-aminopenicillanic acid.
PAA: refers to phenylacetic acid. MIBK: refers to methylbutyl ketone .. Phytosol: refers to 1,1,1,2-tetrafluoroethane. Fitosol D .: refers to a mixture comprising dimethyl ether (at 10% by weight) and 1,1,1,2-tetrafluoroethane (90% by weight) .. All the analyzes referred to herein were carried out using high performance liquid chromatography
(HPLC) as follows: Mobile phase: 25 mM ammonium acetate in 1: 1 methanol / water solution + acetic acid at pH 6.0. Column: column of 3.9 x 300 mm, packing of Ease Reverse C18 of LQ mieras. Detection: 230 nm Injection: 10 μl
The numbers of the examples prefixed with the letter * C "are comparative examples.
Example Cl - Standard (known) method for the preparation of 6-APA
i). Enzymatic Disability of Pen-G
480 ml of water and 30 g of penicillin G were charged into a container in a water bath set at 37 ° C. The mixture was stirred gently until the temperature was stabilized at 37 ° C. 83 g of enzyme resin comprising penicillin-acylase was added on a polymer resin matrix, followed by 5% sodium hydroxide at pH 8.0. Agitation was continued while maintaining the pH of 8.0 and 37 ° C until a resting state was reached. This took approximately 2 hours. The total volume of 5% sodium hydroxide used was usually about 65 ml. The resin with enzyme was filtered through a sintered funnel and the resin was washed with water and stored in a refrigerator for later use. The solution containing 6-APA and PAA was processed as described in (ii) below.
ii) Isolation of 6-APA
The enzyme liquor containing 6-APA and PAA was concentrated to one quarter, then cooled to 5 ° C and an equal volume of MIBK was added. 2 M nitric acid was added dropwise until pH 3.8. The pH was maintained at 3.8 for 1 hour, during which time the free acid of 6-APA was precipitated. Then, the precipitate was filtered, washed with MIBK, then with acetone and dried.
Example 1 - General method according to the embodiment of the present invention
The methods of (iii) and (iv) described hereinafter are alternative, which can be used for the isolation of 6-APA.
i) Apparatus
An apparatus for carrying out the method comprises a reaction vessel and an evaporation vessel, which are lined to provide a means for controlling the temperature. In addition, both containers are
equipped with burettes for the addition of reagents, and a means for stirring, measuring temperature and pH. Both vessels communicate with each other and with a vacuum pump and a gas compressor, so that the reaction streams can be transferred from one vessel to another and a volatile solvent used (as described herein) can be transferred to and from both vessels and to a suitable solvent storage tank. In-line filters, one-way valves and pressure relief valves can be adjusted to allow convenient and safe operation of the device.
ii) Enzymatic Disability of Pen-G
100 ml of water and 40 g of Pen-G were charged to the reaction vessel, followed by 50.6 g of enzyme resin. The container was sealed and evacuated to a pressure below 10 mbar and stirring was started. 1 to 2 kg of Fitosol A were loaded and the temperature stabilized at 37 ° C by flowing hot water through the liner. A pH of 8 was maintained by the addition of 5% sodium hydroxide via the reagent burette
until a state of rest was reached. The total volume of the NaOH solution required was usually around 90 ml.
iii) Isolation of 6-APA
The enzyme liquor containing 6-APA and PAA was reloaded into the reaction vessel. 1 to 2 kg of Fitosol D was loaded and the stirring started. Cooling was applied by flowing cold water through the liner. 2 M nitric acid was slowly added via the reagent burette at pH 3.8 and stirring was continued for 1 hour while maintaining the pH of 3.8. During this time, the free acid of 6-APA was precipitated, while the PAA remained in the solution in the Fitosol D. The reaction mixture was charged to the evaporation vessel via an in-line filter which retained the precipitate 6-APA . The Fitosol D was then recirculated through the reaction vessel (to wash the 6-APA product) and the filter in line for 30 minutes after which the flow of Fitosol D was diverted to the storage cylinder. The precipitate of 6-APA was then isolated from the filter in line. When all the Fitosol D evaporated, the
Remaining aqueous solution contained PAA co or an oily suspension.
iv). Isolation of 6-APA (alternative method)
The enzyme liquor containing 6-APA and PAA was stirred with either Fitosol A or Fitosol D or with an alternative solvent mixture comprising 1,1,1,2-tetrafluoroethane and a co-solvent, for example an aliphatic alcohol, ketone or ether. An inorganic acid, such as 1-4M nitric or sulfuric acid, was slowly added until a pH of less than 2.5 was reached. The pH is suitably adjusted to between 1.5 and 2.0. The temperature during the acid addition was reduced to within the range of 2 to 20 ° c. The two immiscible layers were separated by allowing the mixture to settle and the lower layer comprising the PAA solution in solvent, to be run off. The upper layer containing 6-APA was treated with an aqueous solution of a base such as sodium hydroxide or potassium hydroxide, while stirring at a reduced temperature until a pH of 3.8 was reached, at which pH the 6-APA free acid. The precipitated 6-APA was isolated by filtration.
v) PAA insulation
The aqueous solution comprising the oily suspension of PAA produced in step (iii) was extracted into the Fitosol solvent and the immiscible Fitosol layer containing PAA in solution was separated from the aqueous layer. The isolation of PAA was achieved by causing the Fitosol to evaporate. Alternatively, the PAA can be isolated after step (iv) by evaporating the solvent from the isolated PAA solution.
Example C2 - Preparation of 6-APA
The method of Example Cl was carried out to produce a baseline for comparison with other examples. In the method 30 g of Pen-G were reacted with the immobilized enzyme and the final product (6-APA) was dried, weighed and evaluated using HPLC. The results were as follows: Weight of the Pen-G used = 30.0 g
Weight of the immobilized enzyme = 38.0 g
Volume of water used = 480 ml
Volume of 5% NaOH used = 65 ml
Volume of the enzyme enzyme produced = 550 ml Enzyme enzyme assay = 31,100 μg / ml as 6-APA
Conversion Step Performance = 96% Weight of 6-APA produced = 13.23 g
Full Performance from Pen-G = 74%
Example 2
A suspension was prepared in the reaction vessel containing 40 g of Pen-G, 50 ml of water and 2 kg of Fitosol. 5% sodium hydroxide was added in 2 hours, during which time the pH was maintained at 8.0. The total volume of the sodium hydroxide solution used was 85 ml, indicating complete conversion. At the end of the reaction, the enzyme resin was filtered and the Fitosol evaporated back to its storage tank. Enzyme liquor volume = 160 ml Enzyme liquor test = 142,300 μg / ml Weight of 6-APA produced = 22.76 g Conversion yield = 98.2%
80 ml of the enzyme liquor was precipitated and the 6-APA was isolated following the method described in Example 1 (iii). Weight of 6-APA produced = 9.6 g Complete yield from Pen-G = 84.4%
The product obtained was dried and it was not necessary to dry it in additional vacuum.
Example C3
To provide a direct comparison with the 6-APA isolation step of Example 2, a second 80 ml portion of the enzyme liquor was precipitated using MIBK, washed with acetone and dried in vacuo for 20 hours. Weight of 6-APA produced = 9.45 g Insulation Step yield = 83.0%
Example 3 - Effect of pH on extraction of PAA
This example was carried out to evaluate the efficiency and selectivity of Fitosol D in the extraction of PAA from the enzymatic liquor at different pH's.
The enzyme liquor was prepared as described in Example 1, using the enzyme resin of Example C2. Samples of 20 ml of liquor were extracted with 40 ml of Fitosol D, at various pH's, using the handheld device as follows: The apparatus consists of a 100 ml graduated glass tube, equipped with a filter assembly and a clamping ring which in turn is equipped with a needle valve. The material or solution to be extracted is loaded into the tube. The filter is then assembled with the aid of a sealing O-ring, followed by the clamping ring that ensures a firm fit. The Fitosol liguid-gas is introduced to the glass tube from an aerosol can via a needle valve. The contents of the tube are mixed by vigorous stirring, after which the tube is inverted and allowed to stand until the two layers separate. The Fitosol is then released via the needle valve in an evaporator bottle, taking care not to allow any of the aqueous layer to co-discharge. The results are given in the following table.
Example 4 - Effect of the presence of Fitosol A on the enzyme performance
The experiment was carried out to evaluate the effect of the presence of Fitosol A on the performance of the enzyme - that is (6-APA produced in the enzyme) - (theoretical 6-APA). In the experiment, 30 g of Pen-G was dissolved in 300 ml of water and was deacylated as described in Example 1.
Volume of NaOH at 2.5% used = 134 ml Volume of enzyme liquor produced = 450 ml Enzyme liquor assay = 38,120 μg / ml as 6 -APA Enzyme yield 98.2% of the theoretical
It will be noted that the yield is higher in the presence of Fitosol A (compare Example 4 and Example C2). -
Example Effect of using a more concentrated Pen-G solution
This experiment involved the conversion of a more concentrated solution of Pen-G, with a view to avoiding the need for additional concentration before the step of precipitation and isolation of 6-APA of Example 1 (iii). In the experiment, 30 g of Pen-G was dissolved in 150 ml of water and 2 kg of Fitosol A were used and the method was carried out as described above.
Final volume of the enzyme liquor = 350 ml Enzyme liquor assay 47,800 μg / ml as 6-APA Conversion yield = 96%
6-APA was isolated as described in Example 1 (iii) by the addition of the enzyme liquor to Fitosol D (2 kg) and acidification to pH 3.8 using 1 M nitric acid.
Product weight 6-APA isolated = 5.6 g
It will be appreciated that the concentration of the enzyme liquor used is preferably as high as possible to minimize the losses of the desired 6-APA in the mother liquor.
Example 6 - Isolation of PAA
A previously obtained aqueous effluent solution (300 ml) containing about 14 g of PAA as an oily suspension was charged to the reaction vessel. The Fitosol D was charged to the vessel and the mixture was stirred for 30 minutes. The two layers were allowed to settle by resting for 15 minutes, then separated with the aid of a sintered glass fitted to the lower outlet of the container. The Fitosol D was then evaporated and returned to the storage cylinder. The PAA was collected from the vessel as a blanquecino crystalline solid.
PAA weight recovered = 14.2 g
Although it is difficult to accurately determine the PAA content of the initial solution, yields close to the theoretical appear to be possible.
Example 7 - Use of sulfuric acid for the adjustment of the Pl
The enzyme reaction was carried out as described in general in Example 1 (ii) using 40 g of Pen-G, 61 g of enzyme resin, 50 ml of water, 5% NaOH to maintain pH 8.0 and at a temperature of 37 ° C. The results were as follows:
Volume of enzyme liquor = 145 ml Concentration = 13.2% (by HPLC)
Yield of enzyme passage = 83%
Precipitation and isolation were carried out as described in general in Example 1 (iii), using a mixture of solvents comprising 2 kg of Fitosol and 30 ml of isopropanol. It caused the 6-APA to precipitate
by the addition of 1 M sulfuric acid until pH 3.8, at 4 ° C. The 6-APA was isolated as a white solid. Yield by weight = 14.8 g HPLC analysis showed PAA as a very sticky trace. Preferred embodiments of the present invention may have the following advantages: - the imaging reaction may be carried out in a solution with a higher concentration of Pen-G than hitherto, thereby eliminating or reducing the need for a potentially expensive concentration step. A more efficient enzymatic reaction is achieved which involves a faster reaction and / or improved performance. Conversion yields of 98% or greater have been demonstrated. The activity of the enzyme is not damaged by the solvent system. The need for large quantities of organic solvents is eliminated or reduced, thereby eliminating the problems associated with such solvents such as storage, recovery and treatment of effluents before disposal.
- Fitosol shows good efficiency in the withdrawal of PAA while the solubility of 6-APA in the solvent is negligible. The crystalline forms can be manipulated by the use of a co-solvent during the precipitation of 6-APA, which can be advantageous in the downstream processing. Dry 6-APA is produced directly, without the need for subsequent drying of the product. - In general, the process is faster and cheaper than established industrial processes. Advantageously, the present invention in its broadest terms is not restricted to the dividing enzyme of penicillin and cephalosporin, but is relevant to other related enzymes, including acylases, amidases, proteases and esterases. The solvents described herein can be used to substantially improve reaction rates and isolation of the product in stream line. The reader's attention is directed to all documents that are presented concurrently with or prior to this specification, in relation to this application and which are open to public inspection with this specification, and
The contents of all such documents are incorporated by reference herein. All the features described in this specification (including any claims, summaries and appended drawings), and / or all steps of any method or process described thus, may be combined in any combination, except combinations where at least some of such features and / or steps are mutually exclusive. Each characteristic described in this specification (including any claims, summary and attached drawings) may be replaced by alternative features that serve the same, equivalent or similar purpose, unless otherwise expressly stated. Thus, unless otherwise expressly stated, each characteristic described is an example only of a generic series of eguivalent or similar characteristics. The invention is not restricted to the details of the previous modality (s). The invention extends to any novel or novel combination of the features described in this specification (including any
claims, summary and appended drawings), or any new or novel combination of the steps of any such method or process.
It is noted that in relation to this date, the best method known to the applicant to carry out the aforementioned invention is that which is clear from the present description of the invention.
Claims (17)
1. A method for preparing a second compound by catalytic conversion of a first compound, the method is characterized in that it comprises contacting the first compound and a catalyst in a mixture of solvents comprising water and a first non-aqueous solvent.
2. A method according to claim 1, characterized in that the catalyst is an enzyme.
3. A method according to claim 2, characterized in that the enzyme is sensitive to the second compound, since relatively high concentrations of the second compound reduce the ability of the enzyme to effect the conversion.
4. A method according to claims 2 6 3, characterized by the enzyme is able to catalyze a deacylation reaction.
5. A method according to any of the preceding claims, characterized in that the first compound is of the general formula R1NHQ wherein R1 represents an optionally substituted alkylcarbonyl group and Q represents an optionally substituted cyclic group.
6. A method according to any one of the preceding claims, characterized in that the ratio of the weight of the first solvent to that of the water in the solvent mixture is at least 2.
7. A method according to any one of the preceding claims, characterized in that the ratio, as% p / v, of the first compound to the water present in the mixture, is at least 10.
8. A method according to any of the preceding claims, characterized in that the first non-aqueous solvent has a point of boiling, at atmospheric pressure, less than 80 ° C and greater than -90 ° C.
9. A method according to any of the preceding claims, characterized in that the first solvent is organic.
10. A method according to any one of the preceding claims, characterized in that the first solvent comprises an alkane of 1 to 4 carbon atoms optionally substituted.
11. A method according to any one of the preceding claims, characterized in that the first solvent is halogenated.
12. A method according to any one of the preceding claims, characterized in that the first solvent is non-chlorinated.
13. A method according to any of the preceding claims, characterized in that the first solvent is tetrafluoroethane.
14. A method according to any of the preceding claims, characterized in that it includes the step of isolating the second compound from the other compounds / solvents by causing the precipitation of the second compound and the subsequent isolation of the precipitate.
15. A method according to any one of claims 1 to 13, characterized in that it includes adjusting the pH in the presence of a second solvent to a value at which the second compound is substantially soluble in the aqueous phase of the solvent mixture. , while the by-products of the reaction are substantially soluble in the second non-miscible solvent phase of the solvent mixture.
16. A method according to any of the preceding claims, characterized in that the first compound is a natural penicillin or a biosynthetic penicillin prepared by the addition of a precursor to a fermentation broth of penicillin, or a cephalosporin, and the second compound is the acid 6-aminopenicillanic acid or 7-aminodesacetoxycephalosporanic acid.
17. A method for removing a third compound, for example an acid or acid salt, especially f.-acetylacetic acid, from a mass of material containing the compound, the method is characterized by comprising: a) contacting the mass of material with a solvent to charge the solvent with the third compound; and b) the separation of the charged solvent from the rest of the mass of the material. IMPROVED PROCEDURE FOR THE PREPARATION OF LACTAMA COMPOUNDS SUMMARY OF THE INVENTION Lactams, for example 6-aminopenicillanic acid (6-APA), can be prepared by the enzymatic conversion of a first compound, for example penicillin G, into a mixture of solvents comprising water and a non-aqueous organic solvent, especially 1 , 1, 1, 2- tetrafluoroethane. The 6-APA can be caused to precipitate, be isolated by filtration and optionally derivatized to produce a desired compound. A by-product of the enzymatic conversion, phenylacetic acid, can be isolated by solvent extraction, suitably using a solvent also comprising 1,1,1,2-tetrafluoroethane.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9718740.5 | 1997-09-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA00002250A true MXPA00002250A (en) | 2001-03-05 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2499600A1 (en) | Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b | |
AU751593B2 (en) | Improvements in or relating to the preparation of lactam compounds | |
RU2223323C2 (en) | Method for preparing 6-aminopenicillanic acid (6-apa) | |
MXPA00002250A (en) | Improvements in or relating to the preparation of lactam compounds | |
EP0869961B1 (en) | Process for the recovery of cephalexin | |
EP0485204B1 (en) | Process for the preparation of 3-alkoxymethyl cephalosporin derivatives | |
KR100537732B1 (en) | Preparation of Clavulanate | |
KR100343434B1 (en) | Method of preparing 7-amino-3-methoxymethyl-3-cephem-4-carboxylic acid | |
EP1416054B1 (en) | Simple enzymatic process for preparing cefazolin | |
CZ20001235A3 (en) | Process for preparing lactam compounds. | |
JP2000512510A (en) | Improved method for fermentative production of cephalosporins | |
US4010167A (en) | Method for the recovery of zearalenone | |
WO2004062558A2 (en) | Process for enzymatic synthesis of βετα-lactam antibiotics | |
EP0144170B1 (en) | Biosynthesis of unnatural cephalosporins | |
CZ307497A3 (en) | Method of isolating ampicillin | |
US20010029038A1 (en) | Purification of fermented clavulanic acid | |
EP1957502A1 (en) | Process for the preparation of a potassium salt of penicillin | |
BE817780A (en) | PROCESS FOR CRYSTALLIZATION OF CEPHALEXIN AND PRODUCTS OBTAINED (INV.: K. NARA | |
MXPA01000439A (en) | Improved process for the preparation of salts and esters of clavulanic acid | |
HU191842B (en) | Economical industrial process for the production of high purity d-/-/-penicillamine | |
WO2002018618A2 (en) | PROCESS FOR THE PREPARATION OF A β-LACTAM NUCLEUS AND THE APPLICATION THEREOF | |
MXPA98010768A (en) | Improved process for the fermentative production of cephalosporin | |
EP3331850A1 (en) | Salt of dihydrophenylglycine methyl ester | |
MX2008007066A (en) | Process for the preparation of a potassium salt of penicillin |